BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2759715)

  • 1. Natural killer susceptibility of brain tumor cell lines inversely correlates with the degree of cell differentiation and not with the level of human histocompatibility antigen expression.
    Alonso C; Serrano R; Solana R; Peña J
    Int Arch Allergy Appl Immunol; 1989; 89(2-3):169-72. PubMed ID: 2759715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors.
    Peña J; Alonso C; Solana R; Serrano R; Carracedo J; Ramirez R
    Eur J Immunol; 1990 Nov; 20(11):2445-8. PubMed ID: 1701392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between sensitivity to natural killer cells and MHC class-I antigen expression in colon carcinoma cell lines.
    Blottière HM; Zennadi R; Burg C; Douillard JY; Meflah K; Le Pendu J
    Int J Cancer; 1992 Feb; 50(4):659-64. PubMed ID: 1537634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target-cell sensitivity to natural killer-cell lysis is determined by the expression of a novel antigen in conjunction with major histocompatibility complex class-I molecules.
    Harris DT; Jaso-Friedmann L; Evans DL
    Scand J Immunol; 1994 Jan; 39(1):73-8. PubMed ID: 8290895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells.
    Kaufman DS; Schoon RA; Leibson PJ
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8337-41. PubMed ID: 1325654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histocompatibility antigens and natural killer susceptibility.
    Peña J; Solana R
    Immunol Res; 1992; 11(2):133-40. PubMed ID: 1431422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis.
    Ma D; Niederkorn JY
    Immunology; 1995 Oct; 86(2):263-9. PubMed ID: 7490128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect.
    Ciccone E; Pende D; Nanni L; Di Donato C; Viale O; Beretta A; Vitale M; Sivori S; Moretta A; Moretta L
    Int Immunol; 1995 Mar; 7(3):393-400. PubMed ID: 7794819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain.
    Yamasaki T; Moritake K; Klein G
    J Neurosurg; 2003 Mar; 98(3):599-606. PubMed ID: 12650434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.
    Maio M; Altomonte M; Tatake R; Zeff RA; Ferrone S
    J Clin Invest; 1991 Jul; 88(1):282-9. PubMed ID: 1905328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition.
    Kaufman DS; Schoon RA; Leibson PJ
    J Immunol; 1993 Feb; 150(4):1429-36. PubMed ID: 8432986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products.
    Itescu S; Artrip JH; Kwiatkowski PA; Wang SF; Minanov OP; Morgenthau AS; Michler RE
    Ann Transplant; 1997; 2(1):14-20. PubMed ID: 9869836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity.
    Liao NS; Bix M; Zijlstra M; Jaenisch R; Raulet D
    Science; 1991 Jul; 253(5016):199-202. PubMed ID: 1853205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression.
    Shimizu Y; DeMars R
    Eur J Immunol; 1989 Mar; 19(3):447-51. PubMed ID: 2707298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells.
    Stam NJ; Kast WM; Voordouw AC; Pastoors LB; van der Hoeven FA; Melief CJ; Ploegh HL
    J Immunol; 1989 Jun; 142(11):4113-7. PubMed ID: 2541206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class I expression on human tumour cells and their susceptibility to NK lysis.
    Pena J; Solana R; Alonso MC; Santamaria M; Serrano R; Ramirez R; Carracedo J
    J Immunogenet; 1989; 16(4-5):407-12. PubMed ID: 2517951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
    Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
    J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F; Kajiwara M
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
    Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
    J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.